Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer
- PMID: 28283588
- PMCID: PMC5354479
- DOI: 10.1074/jbc.A117.553818
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer
Erratum for
-
Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer.J Biol Chem. 2014 Sep 19;289(38):26417-26429. doi: 10.1074/jbc.M114.553818. Epub 2014 Aug 1. J Biol Chem. 2014. PMID: 25086042 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
